Protonix News and Research

RSS
Potential side effects increase in children with use of common reflux aids, study shows

Potential side effects increase in children with use of common reflux aids, study shows

Study links heartburn drugs to fatal cases of heart, kidney disease and gastrointestinal cancer

Study links heartburn drugs to fatal cases of heart, kidney disease and gastrointestinal cancer

Common medications to treat heartburn linked to increased risks for kidney failure

Common medications to treat heartburn linked to increased risks for kidney failure

Prolonged use of popular heartburn drugs linked to silent, gradual kidney damage

Prolonged use of popular heartburn drugs linked to silent, gradual kidney damage

Common heartburn medications could decrease effects of chemotherapy in cancer patients

Common heartburn medications could decrease effects of chemotherapy in cancer patients

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Brazilian study provides evidence to support effectiveness of Tecta in erosive GERD

Brazilian study provides evidence to support effectiveness of Tecta in erosive GERD

Pfizer receives $2.15 billion settlement from Teva and Sun for patent-infringement damages

Pfizer receives $2.15 billion settlement from Teva and Sun for patent-infringement damages

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Phase III clinical trial data of Milprosa vaginal ring presented at PCRS annual meeting

Phase III clinical trial data of Milprosa vaginal ring presented at PCRS annual meeting

FDA approves Teva's Quartette tablets for prevention of pregnancy

FDA approves Teva's Quartette tablets for prevention of pregnancy

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD

FDA approves Teva’s generic Adderall XR ANDA for treatment of ADHD

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI

Teva terminates collaboration with CureTech

Teva terminates collaboration with CureTech

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.